Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001140361-23-003177

President and CEO sold 55,000 shares at an average $35.32 ($1,942,336)

  • President and CEO acquired 30,000 shares (option exercise)
  • President and CEO acquired 146,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Coulie Bernard President and CEO 2023-01-25 Grant or award +146,300 240,112 D
Coulie Bernard President and CEO 2023-01-26 Option exercise +15,000 $2.08 $31,200 255,112 D
Coulie Bernard President and CEO 2023-01-26 Sale −15,000 $35.29 $529,367 240,112 D
Coulie Bernard President and CEO 2023-01-26 Sale −15,000 $35.10 $526,425 419,317 I
Coulie Bernard President and CEO 2023-01-27 Option exercise +15,000 $2.08 $31,200 255,112 D
Coulie Bernard President and CEO 2023-01-27 Sale −8,698 $35.42 $308,046 246,414 D
Coulie Bernard President and CEO 2023-01-27 Sale −6,302 $36.06 $227,243 240,112 D
Coulie Bernard President and CEO 2023-01-27 Sale −9,779 $35.09 $343,158 409,538 I
Coulie Bernard President and CEO 2023-01-27 Sale −221 $36.64 $8,097 409,317 I
Derivatives
Coulie Bernard President and CEO 2023-01-25 Grant or award · Stock Option (right to buy) +206,300 206,300 D
Coulie Bernard President and CEO 2023-01-26 Option exercise · Stock Option (right to buy) −15,000 187,380 D
Coulie Bernard President and CEO 2023-01-26 Option exercise · Stock Option (right to buy) −15,000 172,380 D
Open-market sales · 55,000 sh · avg $35.32 · $1,942,336
Loading xslF345X03/form4.xml…